7 Peptides

Best Peptides for Joint Pain & Repair

Peptides researched for joint health, cartilage repair, arthritis relief, and connective tissue support.

7Total Options
1FDA Approved

Understanding Joint Pain Peptides

Joint pain peptides target the underlying causes of joint deterioration rather than just masking symptoms. BPC-157 has shown protective effects on cartilage and tendon-to-bone healing in animal models. TB-500 promotes cell migration essential for tissue repair. GHK-Cu supports connective tissue remodeling. Growth hormone peptides may indirectly support joint health through improved collagen synthesis and tissue regeneration. These compounds are increasingly researched as alternatives or complements to traditional joint treatments.

Key Considerations

  • BPC-157 injected near the affected joint may provide localized benefits
  • Combining BPC-157 with TB-500 is a common protocol for joint issues
  • GH secretagogues may support joint health through improved collagen production
  • Physical therapy and proper movement remain essential
  • Severe joint damage may require medical intervention beyond peptides

FDA Approved Options (1)

Research Peptides (6)

These peptides are being researched but are not FDA approved. They should only be considered for research purposes or under medical supervision.

BPC-157

Preclinical

A synthetic peptide derived from a protein found in human gastric juice. Known for its remarkable tissue healing properties across multiple body systems. FDA classified as Category 2 in 2023, restricting compounding.

HealingLearn more

TB-500

Preclinical

A synthetic 17-amino acid fragment of Thymosin Beta-4 (TB-4). Unlike TB-4, TB-500 has a longer half-life (~2-4 days vs ~2 hours) and is the active region responsible for tissue repair and cell migration. Note: Many vendors mislabel TB-4 as 'TB-500' in premixed products.

HealingLearn more

Cartalax

Preclinical

A synthetic tripeptide bioregulator targeting cartilage tissue. Developed for joint health and cartilage regeneration.

BioregulatorsLearn more

Wolverine Stack

Preclinical

The most popular healing peptide combination, combining BPC-157 (10mg) and TB-500 (10mg). Named after the Marvel character's regenerative abilities. Used for accelerated injury recovery, joint support, and tissue repair.

Peptide BlendLearn more

Pentadecapeptide

Preclinical

The full 15-amino acid sequence that includes BPC-157. While BPC-157 is more commonly discussed, the full pentadecapeptide has similar healing properties derived from gastric juice.

HealingLearn more

Thymosin Beta-4

Clinical Trials

The full 43-amino acid protein that TB-500 is derived from. Naturally occurring in most human tissues, TB-4 has a shorter half-life (~2 hours) compared to its synthetic fragment TB-500 (~2-4 days). Often mislabeled as 'TB-500' by vendors in premixed products.

HealingLearn more

Frequently Asked Questions

What is the best peptide for joint pain?

BPC-157 is the most commonly researched peptide for joint issues, with animal studies showing cartilage protection, reduced inflammation, and accelerated tendon-to-bone healing. TB-500 complements it by promoting cell migration for tissue repair.

Can peptides repair cartilage?

Preclinical research suggests BPC-157 has chondroprotective effects (protects cartilage) and may support cartilage repair. However, severe cartilage loss (bone-on-bone) is unlikely to be fully reversed by any peptide alone.

How do I use BPC-157 for joint pain?

Community protocols typically involve subcutaneous injection near the affected joint at 250-500 mcg, 1-2 times daily, for 4-8 weeks. Some protocols combine it with TB-500. This is anecdotal — no human trials exist for this specific application.

Explore Other Goals

Compare Peptides Side-by-Side

Use our comparison tool to evaluate multiple peptides at once.

Open Compare Tool

Looking for a trusted vendor?

Pro members get access to verified vendors with quality standards & exclusive discount codes.

View Verified Vendors
PRO

Get Weekly Peptide Research Updates

New peptides, studies, and FDA changes delivered to your inbox.